Jynarque 90MG/30MG
Ended Awarded
- Contract number
- 36C24522N0150
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,299
Award facts
- Contract value 99% obligated
- $10,375.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Deerfield, IL 60015, USA
Award details come from SAM.gov/FPDS.
About this award
Otsuka America Pharmaceutical Inc. was awarded a delivery order by Veterans Integrated Service Network 5 (VISN 5) for Jynarque 90mg/30mg on November 12, 2021, with a ceiling value of $10,375.04. The contract is firm fixed price with no set-aside designation and was completed by November 17, 2021. This delivery order was issued under the company's broader Blanket Purchase Agreement for Jynarque valued at $83.3 million with the VA's National Acquisition Center, which operates under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with completion through March 26, 2026.
Jynarque (tolvaptan) is a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia in veteran populations. Otsuka America Pharmaceutical Inc., headquartered in Rockville, Maryland, serves as a primary supplier of specialized pharmaceuticals to the Department of Veterans Affairs across multiple Veterans Integrated Service Networks. The VA's utilization of indefinite delivery vehicles and blanket purchase agreements for this medication enables efficient procurement and distribution of this critical treatment to veterans nationwide. The place of performance for this delivery order was Riverwoods, Illinois.
Quick answers
Who was awarded contract 36C24522N0150?
36C24522N0150 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on November 12, 2021.
How much is contract 36C24522N0150 worth?
The government has obligated $10,299 on 36C24522N0150. Its current value, with exercised options, is $10,375.
Is contract 36C24522N0150 an order under another contract?
Yes. 36C24522N0150 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24522N0150 competed?
The extent of competition for 36C24522N0150 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award